Loading…
science
Hosted by Unknown Host · science · EN · 14 episodes
Welcome to Talking Transfusion: The Transfusion Evidence Round-Up Podcast! Join Dr. Allison Mo and co-chairs Susan Brunskill and Catherine Kimber as they explore high-quality systematic reviews and randomized controlled trials in transfusion medicine. Each episode highlights key studies, offering insights into their implications for clinical practice. With expert guests sharing diverse perspectives, we bridge the gap between research and practice, empowering healthcare professionals to make informed decisions. Subscribe now and stay updated on the latest evidence shaping transfusion practices!
Required Pod Score for this show. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Public web form
Booking probability
28%
Guest openness
Selective
Sign up to generate a grounded pitch for Talking Transfusion: The Transfusion Evidence Round-Up Podcast.
Signup to Generate a PitchTalking Transfusion: The Transfusion Evidence Round-Up Podcast is a science podcast hosted by Unknown Host, with 14 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.
Unknown Host hosts Talking Transfusion: The Transfusion Evidence Round-Up Podcast, a science show with 14 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Episode #7
<p>In honour of International Thalassaemia Day, in this podcast episode, we explore top research relating to transfusion and stem cell transplantation in people with thalassaemia. Our reviewers cover a range of topics including novel oral treatments, different preparations of red blood cell products and allogeneic haematopoietic stem cell transplantation. </p>
Episode #6
<p>Welcome to this special quarterly edition of the Transfusion Evidence Round-Up, produced by the International Society of Blood Transfusion (ISBT) and the Transfusion Evidence Library (TEL). In honor of International Childhood Cancer Day, we’ve partnered with the ISBT Cellular Therapies Working Group to bring you a joint Round-Up highlighting the latest evidence in both Transfusion Medicine and Cell Therapy.</p><p>In this episode, we explore top research shaping pediatric hematology and stem cell transplantation, including the impact of minimal residual disease on outcomes in childhood acute lymphoblastic leukemia from the FORUM Trial. We also highlight advances in TC...
Talking Transfusion: The Transfusion Evidence Round-Up Podcast
<p>In this episode of Talking Transfusion: The Transfusion Evidence Round-Up Podcast, we speak to the reviewers of the December Transfusion Evidence Round-Up. The theme of the round-up was "Best of Transfusion Evidence Library 2025", and covered a variety of papers encompassing a wide range of important and interesting transfusion topics. </p>
Talking Transfusion: The Transfusion Evidence Round-Up Podcast
<p>Did you miss the Blood 2025 and ISBT Perth 2025 Congress? Or perhaps you joined us in Perth and are now looking to dive deeper or revisit the highlights?</p><p>In this podcast episode, Allison Mo (hematologist from Melbourne, Australia) and Catherine Kimber and Susan Brunskill (from the Systematic Reviews Initiative, UK) sit down with two special guests, Pierre Tiberghien and Aaron Hess, to reflect on their experiences at the joint Blood and ISBT Congress held in Perth in October 2025.</p><p>Our guests share their perspectives, memorable moments, and key takeaways from the event. Pierre Tiberghien is the ISBT...
Talking Transfusion: The Transfusion Evidence Round-Up Podcast
<p>September is Blood Cancer Awareness Month, a time to highlight one of the world’s most prevalent and serious cancers. In this episode of Talking Transfusion, hosts Allison Mo (hematologist from Melbourne, Australia) and Catherine Kimber (from the Systematic Reviews Initiative, UK), speaks with reviewers from the September Transfusion Evidence Roundup. Together, they explore recent articles on transfusion in blood cancer care—covering the latest findings, clinical challenges, and the crucial role transfusion support plays for patients living with leukemia, lymphoma, myeloma, and related conditions. This discussion brings evidence and awareness together, underscoring how research drives better outcomes for pati...
Recent guests on Talking Transfusion: The Transfusion Evidence Round-Up Podcast. Study who booked and why before you pitch.
Sponsor detection runs nightly. Check back soon.
Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
FAQs
If you have a concern about deliverability, AI quality, data privacy, or whether this will actually work for your specific situation, it's probably answered below.
Founder Solo gives you 50 AI pitches per month using the credit model (Standard pitches cost 1 credit, Enriched pitches cost 2). Founder Pro raises that to 200 credits per month and adds full Booking Probability access, unlimited Magic Match, Apollo enrichment credits, and data export capabilities. Both plans use the same credit system, so you can stretch your monthly budget further by using Standard-mode drafting.
Agency tiers have no base fee. You pay per managed client and per talent profile. Agency Standard is $199 per client per month; Agency Pro is $399 per client per month. Both add $39 per talent profile per month. Your own team's user seats are always free.
A talent profile represents one person (founder, executive, or spokesperson) you are booking onto podcasts. It includes their bio, topics, headshots, and outreach history. Team plans include 5 profiles; agency plans are pay-as-you-go.
Yes, at any time. Upgrades take effect immediately; downgrades apply at the end of the current billing period. Contact support if you need help migrating between plan families.
Every paid plan includes a 15-day free trial. Your card is saved at signup but you will not be charged until day 16. Cancel any time from your dashboard.
You keep access until the end of your current billing period. No charges after that. Your data is retained for 30 days in case you reactivate.
Yes. Select Annual on the pricing toggle and the discounted price is applied automatically at checkout. The annual price shown is the full year cost.
That is our Enterprise tier. Contact our sales team and we will build a custom plan with volume pricing, a dedicated account manager, and SLA guarantees.
